The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Typhim Vi Solution for Injection Typhoid Polysaccharide Vaccine

Sanofi PasteurPA2131/011/001

Main Information

Trade NameTyphim Vi Solution for Injection Typhoid Polysaccharide Vaccine
Active SubstancesSalmonella typhi, vi antigen
Dosage FormSolution for injection
Licence HolderSanofi Pasteur
Licence NumberPA2131/011/001

Group Information

ATC CodeJ07AP03 typhoid, purified polysaccharide antigen


License statusAuthorised
Licence Issued18/08/1992
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches of vaccine marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC as amended.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back